The Complex Patient Scenarios program is designed to offer REI specialists first-hand patient management observations from both Canadian and international experts. With constantly evolving research in the field of fertility, more patients with complex challenges come to the forefront hoping to get fertility care that brings them closer to their goal of conception. Have a listen to how our panel of multidisciplinary experts approach 4 dynamic and challenging patient scenarios.
Please complete the program evaluation upon watching at least one presentation. CLICK HERE TO ACCESS PROGRAM EVALUATION
Veuillez remplir l’évaluation du programme après avoir regardé au moins une présentation. CLIQUEZ ICI POUR ACCÉDER À L'ÉVALUATION DU PROGRAMME
From Poor Responder to Poor Diagnosis: The POSEIDON Subgroups and their Management Dr. Robert Fischer, Medical Director, Fertility Center, Hamburg, Germany
Canadian Contextualization: How are patients with low and poor response or prognosis treated in Canada Dr. Michael Dahan, MD, FACOG, FRCSC, Assistant Professor, Department of Obstetrics and Gynecology, McGill University
You are encouraged to complete these reflection questions to reinforce new learnings from the webinars. Please note that the responses are collected aggregately. No individual information is recorded.
Nous vous encourageons à répondre à ces questions de réflexion afin de renforcer les nouvelles connaissances acquises lors des webinaires. Veuillez noter que les réponses sont collectées de manière globale. Aucune information individuelle n'est enregistrée.
Challenging Cases in Oncofertility Dr. Joseph Letourneau, MD, The Utah Center for Reproductive Medicine, Assistant Professor, University of Utah Dr. Shu Foong, MD, FRCSC, Medical Director, Regional Fertility Program, Clinical Assistant Professor, Department of Obstetrics and Gynecology, University of Calgary
You are encouraged to complete these reflection questions to reinforce new learnings from the webinars. Please note that the responses are collected aggregately. No individual information is recorded.
Nous vous encourageons à répondre à ces questions de réflexion afin de renforcer les nouvelles connaissances acquises lors des webinaires. Veuillez noter que les réponses sont collectées de manière globale. Aucune information individuelle n'est enregistrée.
Recurrent Implantation Failure (RIF): How should we define and manage it? Prof. Nicholas Macklon, MB, CHB, MD, FRCOG, Group Medical Director, London Women’s Clinic, UK and Honorary Professor, Zealand University Hospital, Denmark
Recurrent Implantation Failure (RIF): The Canadian Perspective Dr. Sony Sierra, MD, FRCSC, REI, Deputy Medical Director and Partner, TRIO Fertility, Medical Director, EVOLVE Egg Freezing Clinic, Reproductive Endocrinology and Infertility Specialist
You are encouraged to complete these reflection questions to reinforce new learnings from the webinars. Please note that the responses are collected aggregately. No individual information is recorded.
Nous vous encourageons à répondre à ces questions de réflexion afin de renforcer les nouvelles connaissances acquises lors des webinaires. Veuillez noter que les réponses sont collectées de manière globale. Aucune information individuelle n'est enregistrée.
PGT-A: Navigating Mosaicism: The Biology Behind the Behaviour Dr. David F. Albertini, Editor-in-Chief, Journal of assisted reproduction and Genetics, Professor of Reproductive Cell Biology, Bedford Research Foundation
Transfer of Mosaic Embryos: Clinical Results – Canadian Experience Dr. Clifford L. Librach, MD, FRCS(C), FACOG (REI), Founder and Director, CReATe Fertility Centre and CReATe Cord Blood Bank (Toronto, Ontario), Professor, Department of Obstetrics and Gynecology, University of Toronto
You are encouraged to complete these reflection questions to reinforce new learnings from the webinars. Please note that the responses are collected aggregately. No individual information is recorded.
Nous vous encourageons à répondre à ces questions de réflexion afin de renforcer les nouvelles connaissances acquises lors des webinaires. Veuillez noter que les réponses sont collectées de manière globale. Aucune information individuelle n'est enregistrée.
CA-NONGM-00006
Publication of Merck KGaA, Darmstadt, Germany
Copyright 2025 Merck KGaA, Darmstadt, Germany or its affiliates. All rights reserved.
EMD Serono is the Canadian healthcare business of Merck KGaA, Darmstadt, Germany, with innovative products and devices, and industry-leading patient support and access programs. EMD Serono has deep expertise in neurology, fertility and endocrinology, and a pipeline in neurology, oncology, immunology and immuno-oncology. EMD Serono is headquartered in Mississauga, Ontario.
© 2025 Merck KGaA, Darmstadt, Germany or its affiliates
